CY6463

· Tisento Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CY6463, covering 2024-08-13 to 2024-10-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology [Phase 2]